. Author manuscript; available in PMC: 2019 Sep 1.

Published in final edited form as: Prostate Cancer Prostatic Dis. 2017 Dec 20;21(3):364–372. doi: 10.1038/s41391-017-0009-6

Table 4.

Time to BCR in the total cohort and by pathologic parameters.

Pathologic Parameter	N	Number of Events	Median, year (95% CI)	BCR Free Rate
Pathologic Parameter	N	Number of Events	Median, year (95% CI)	2-Year (95% CI)	3-Year (95% CI)
All patients	72	23	5.1 (4.4, NR)	75% (63%, 84%)	70% (57%, 80%)
Pathologic T Downstaging
Yes	10	0	NR	100%	100%
No	57	20	5.1 (3.3, NR)	74% (60%, 84%)	67% (52%, 79%)
Largest cross section dimension
≤0.5 cm	11	0	NR	100%	100%
>0.5 cm	55	20	5.1 (3.3, NR)	74% (60%, 84%)	67% (52%, 79%)

NR=Not reached.

Exclude patients who did not have pathologic parameters because surgery was done at outside hospitals or tumor measures (i.e. T stage or Largest Cross Section Dimension) were not available from the original trials.